Meltem Caglar Oskayli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Meltem Caglar Oskayli has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Çiğdem Ulukaya Durakbaşa
Department of Pediatric Surgery, İstanbul Medeniyet University, İstanbul, Türkiye
5 shared publications - Ahmet Pirim
Istanbul Medeniyet University, Turkey
3 shared publications - Aşan Önder
Medeniyet University Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Pediatric Endocrinology Clinic, Istanbul, Turkey
2 shared publications - Burhan Aksu
Çocuk Cerrahisi Anabilim Dalı, İstanbul-TÜRKİYE
2 shared publications - Ibrahim Ali Ozemir
Medeniyet Üniversitesi Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi
2 shared publications - Meltem Özkök
İstanbul Medeniyet Üniversitesi
2 shared publications
Latest Publications
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70564
Revisiting VACTERL Association in Patients With Esophageal Atresia With an Emphasis on Skeletal Anomalies
Background: This study aimed to characterize VACTERL‐associated anomalies in patients with esophageal atresia (EA), with particular emphasis on skeletal anomalies. Methods: 168 EA patients were evaluated as those with a distal TEF (D‐TEF) (86.9%), those without D‐TEF (9.5%), and isolated TEF (3.6%). In the D‐TEF subgroup, a gap length of ≥ 4 vertebral‐body was defined as long‐gap EA (15.8%). Baseline neonatal chest and spine radiographs were reviewed using a standardized protocol. Results: The mean gestational age was 36.41 ± 3.04 weeks. The mean birth weight was 2525.35 ± 728.52 g. Long‐gap D‐TEF patients had lower gestational age and birth weight ( p = 0.014 and p = 0.001, respectively). Vertebral, rib, renal, limb, and cardiac anomalies and anorectal malformations (ARM) were present in 17.9%, 14.9%, 19.6%, 9.5%, 38.1%, and 12.5%, respectively. Vertebral and rib anomalies were significantly associated ( p < 0.05). Exploratory analyses suggested differences in vertebral‐anomaly location across EA subtypes (nominal p = 0.038) and in limb‐anomaly frequency across anatomic EA subtypes (nominal p = 0.047). ARM was more frequent in long‐gap than short‐gap D‐TEF (30.4% vs. 8.9%; p = 0.010). It remained significant across sensitivity analyses using alternative gap‐length thresholds. VACTERL association was present in 25.0% of the cohort, without a significant association with anatomic subtype. Conclusions: Skeletal anomalies were common across EA phenotypes with possible subtype‐related differences in their distribution. A standardized assessment on baseline radiographs may improve VACTERL phenotyping and provide a more accurate description of the musculoskeletal burden in patients with EA. The association between ARM and greater gap length in D‐TEF should be interpreted within the present cohort and the study‐specific gap‐length definition.
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70564
Revisiting VACTERL Association in Patients With Esophageal Atresia With an Emphasis on Skeletal Anomalies
Background: This study aimed to characterize VACTERL‐associated anomalies in patients with esophageal atresia (EA), with particular emphasis on skeletal anomalies. Methods: 168 EA patients were evaluated as those with a distal TEF (D‐TEF) (86.9%), those without D‐TEF (9.5%), and isolated TEF (3.6%). In the D‐TEF subgroup, a gap length of ≥ 4 vertebral‐body was defined as long‐gap EA (15.8%). Baseline neonatal chest and spine radiographs were reviewed using a standardized protocol. Results: The mean gestational age was 36.41 ± 3.04 weeks. The mean birth weight was 2525.35 ± 728.52 g. Long‐gap D‐TEF patients had lower gestational age and birth weight ( p = 0.014 and p = 0.001, respectively). Vertebral, rib, renal, limb, and cardiac anomalies and anorectal malformations (ARM) were present in 17.9%, 14.9%, 19.6%, 9.5%, 38.1%, and 12.5%, respectively. Vertebral and rib anomalies were significantly associated ( p < 0.05). Exploratory analyses suggested differences in vertebral‐anomaly location across EA subtypes (nominal p = 0.038) and in limb‐anomaly frequency across anatomic EA subtypes (nominal p = 0.047). ARM was more frequent in long‐gap than short‐gap D‐TEF (30.4% vs. 8.9%; p = 0.010). It remained significant across sensitivity analyses using alternative gap‐length thresholds. VACTERL association was present in 25.0% of the cohort, without a significant association with anatomic subtype. Conclusions: Skeletal anomalies were common across EA phenotypes with possible subtype‐related differences in their distribution. A standardized assessment on baseline radiographs may improve VACTERL phenotyping and provide a more accurate description of the musculoskeletal burden in patients with EA. The association between ARM and greater gap length in D‐TEF should be interpreted within the present cohort and the study‐specific gap‐length definition.
- Open Access
- 23 June 2022
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 37 (2) , 137-144
Gastrointestinal Tract Duplications in Children: A Tertiary Referral Center Experience
Gastrointestinal duplications are rare congenital anomalies. Herein, we present a single institutional experience in pediatric gastrointestinal tract duplications. Patient records from 2014 to 2019 were retrospectively evaluated for demographic data, clinical presentation, diagnostic methods, surgical findings, and pathological reports. This study included 19 patients, of whom 10 were males and nine were females, with a median age of 30 (21 days-15.5 years) months. Three patients were antenatally and three were incidentally diagnosed. Abdominal pain, vomiting, constipation, and perianal accessory orifice were the most common presenting symptoms. Preoperative diagnostic workup included ultrasonography (n=13), cross-sectional imaging (n=8), and nuclear scintigraphy (n=1). A preoperative diagnosis was possible in 14 (74%) patients. The duplications originated from the foregut in seven (37%) patients, midgut in seven (37%), and hindgut in five (26%). Cystic duplications were observed in 14 (74%) patients and tubular in five (26%). The total surgical excision with (n=8) or without (n=10) associated organ resection was possible in 18 patients. Partial cyst excision with a complete mucosal removal was done in 1 patient. Heterotopic mucosa was present in six (32%) specimens. The respiratory origin with thyroid transcription factor-1 positivity was contained in two para-esophageal duplications. Among five patients with heterotopic gastric mucosa, 1 had presented with perforation and the others with hemorrhage. Duplications may involve any gastrointestinal segment. The clinical presentation is highly variable because of the wide variation in the involved segment and sizes and the possibility of bearing heterotopic mucosa. The surgery aims to totally excise the cyst or at least totally remove the inner mucosal lining.
- 23 June 2022
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 37 (2) , 137-144
Open AccessGastrointestinal Tract Duplications in Children: A Tertiary Referral Center Experience
Gastrointestinal duplications are rare congenital anomalies. Herein, we present a single institutional experience in pediatric gastrointestinal tract duplications. Patient records from 2014 to 2019 were retrospectively evaluated for demographic data, clinical presentation, diagnostic methods, surgical findings, and pathological reports. This study included 19 patients, of whom 10 were males and nine were females, with a median age of 30 (21 days-15.5 years) months. Three patients were antenatally and three were incidentally diagnosed. Abdominal pain, vomiting, constipation, and perianal accessory orifice were the most common presenting symptoms. Preoperative diagnostic workup included ultrasonography (n=13), cross-sectional imaging (n=8), and nuclear scintigraphy (n=1). A preoperative diagnosis was possible in 14 (74%) patients. The duplications originated from the foregut in seven (37%) patients, midgut in seven (37%), and hindgut in five (26%). Cystic duplications were observed in 14 (74%) patients and tubular in five (26%). The total surgical excision with (n=8) or without (n=10) associated organ resection was possible in 18 patients. Partial cyst excision with a complete mucosal removal was done in 1 patient. Heterotopic mucosa was present in six (32%) specimens. The respiratory origin with thyroid transcription factor-1 positivity was contained in two para-esophageal duplications. Among five patients with heterotopic gastric mucosa, 1 had presented with perforation and the others with hemorrhage. Duplications may involve any gastrointestinal segment. The clinical presentation is highly variable because of the wide variation in the involved segment and sizes and the possibility of bearing heterotopic mucosa. The surgery aims to totally excise the cyst or at least totally remove the inner mucosal lining.
- 22 December 2021
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- p. 423-426
A rare cause of hypercalcemia: two cases of parathyroid adenoma
Hypercalcemia is a rare but serious metabolic condition that may lead to end-organ damage. Primary hyperparathyroidism is a rare disease in children and adolescents and parathyroid adenoma is the most common cause. Most of patients are clinically symptomatic and may present signs or symptoms of hypercalcemia. The aim of this report is to describe two case of hypercalcemia due to parathyroid adenoma presenting with different clinical findings. 14 years old male patient with abdominal pain, vomiting and nausea were diagnosed with acute pancreatitis. His laboratory findings were elevated amylase and lipase levels, hyperglycemia, hypercalcemia and hyperparathyroidism. Parathyroid scintigraphy showed the presence of an adenoma. Normocalcemia was provided with pamidronate and hyperglycemia was treated with insulin. Adenoma excision was performed after acute pancreatitis was recovered with replacement therapy. After the surgery, diabetes mellitus persisted and he had a hungry bone syndrome. Other patient was a 12-year-old male patient presented with complaints of anorexia, weakness, constipation and nausea. He had hypercalcemia, hypophosphatemia and hyperparathyroidism. Parathyroid adenoma was detected with parathyroid scintigraphy. Adenoma excision was performed and postoperatively he had a hungry bone syndrome. Hypercalcemia associated with primary hyperparathyroidism is rare but generally symptomatic in children and adolescents. It should be kept in mind in the differential diagnosis of hypercalcemia and patients should be protected from complications and permanent damage.
- 22 December 2021
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- p. 423-426
A rare cause of hypercalcemia: two cases of parathyroid adenoma
Hypercalcemia is a rare but serious metabolic condition that may lead to end-organ damage. Primary hyperparathyroidism is a rare disease in children and adolescents and parathyroid adenoma is the most common cause. Most of patients are clinically symptomatic and may present signs or symptoms of hypercalcemia. The aim of this report is to describe two case of hypercalcemia due to parathyroid adenoma presenting with different clinical findings. 14 years old male patient with abdominal pain, vomiting and nausea were diagnosed with acute pancreatitis. His laboratory findings were elevated amylase and lipase levels, hyperglycemia, hypercalcemia and hyperparathyroidism. Parathyroid scintigraphy showed the presence of an adenoma. Normocalcemia was provided with pamidronate and hyperglycemia was treated with insulin. Adenoma excision was performed after acute pancreatitis was recovered with replacement therapy. After the surgery, diabetes mellitus persisted and he had a hungry bone syndrome. Other patient was a 12-year-old male patient presented with complaints of anorexia, weakness, constipation and nausea. He had hypercalcemia, hypophosphatemia and hyperparathyroidism. Parathyroid adenoma was detected with parathyroid scintigraphy. Adenoma excision was performed and postoperatively he had a hungry bone syndrome. Hypercalcemia associated with primary hyperparathyroidism is rare but generally symptomatic in children and adolescents. It should be kept in mind in the differential diagnosis of hypercalcemia and patients should be protected from complications and permanent damage.
- 22 December 2021
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 60 (4) , 423-426
A rare cause of hypercalcemia : Two cases of parathyroid adenoma
Hypercalcemia is a rare but serious metabolic condition that may lead to end-organ damage. Primary hyperparathyroidism is a rare disease in children and adolescents and parathyroid adenoma is the most common cause. Most of patients are clinically symptomatic and may present signs or symptoms of hypercalcemia. The aim of this report is to describe two case of hypercalcemia due to parathyroid adenoma presenting with different clinical findings. 14 years old male patient with abdominal pain, vomiting and nausea were diagnosed with acute pancreatitis. His laboratory findings were elevated amylase and lipase levels, hyperglycemia, hypercalcemia and hyperparathyroidism. Parathyroid scintigraphy showed the presence of an adenoma. Normocalcemia was provided with pamidronate and hyperglycemia was treated with insulin. Adenoma excision was performed after acute pancreatitis was recovered with replacement therapy. After the surgery, diabetes mellitus persisted and he had a hungry bone syndrome. Other patient was a 12-year-old male patient presented with complaints of anorexia, weakness, constipation and nausea. He had hypercalcemia, hypophosphatemia and hyperparathyroidism. Parathyroid adenoma was detected with parathyroid scintigraphy. Adenoma excision was performed and postoperatively he had a hungry bone syndrome. Hypercalcemia associated with primary hyperparathyroidism is rare but generally symptomatic in children and adolescents. It should be kept in mind in the differential diagnosis of hypercalcemia and patients should be protected from complications and permanent damage.
- 22 December 2021
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 60 (4) , 423-426
A rare cause of hypercalcemia : Two cases of parathyroid adenoma
Hypercalcemia is a rare but serious metabolic condition that may lead to end-organ damage. Primary hyperparathyroidism is a rare disease in children and adolescents and parathyroid adenoma is the most common cause. Most of patients are clinically symptomatic and may present signs or symptoms of hypercalcemia. The aim of this report is to describe two case of hypercalcemia due to parathyroid adenoma presenting with different clinical findings. 14 years old male patient with abdominal pain, vomiting and nausea were diagnosed with acute pancreatitis. His laboratory findings were elevated amylase and lipase levels, hyperglycemia, hypercalcemia and hyperparathyroidism. Parathyroid scintigraphy showed the presence of an adenoma. Normocalcemia was provided with pamidronate and hyperglycemia was treated with insulin. Adenoma excision was performed after acute pancreatitis was recovered with replacement therapy. After the surgery, diabetes mellitus persisted and he had a hungry bone syndrome. Other patient was a 12-year-old male patient presented with complaints of anorexia, weakness, constipation and nausea. He had hypercalcemia, hypophosphatemia and hyperparathyroidism. Parathyroid adenoma was detected with parathyroid scintigraphy. Adenoma excision was performed and postoperatively he had a hungry bone syndrome. Hypercalcemia associated with primary hyperparathyroidism is rare but generally symptomatic in children and adolescents. It should be kept in mind in the differential diagnosis of hypercalcemia and patients should be protected from complications and permanent damage.
- 1 December 2020
- Published by Wiley in Pediatrics International
- Vol. 62 (12) , 1369-1373
Percutaneous endoscopic gastrostomy in small infants unable to swallow safely
Background Data about percutaneous endoscopic gastrostomy (PEG) insertions in small infants are limited, and most studies include older children. We aimed to evaluate the safety of PEG placement in infants weighing <= 5 kg together with their follow-up results. Methods A retrospective evaluation was made of records between January 2005 and December 2019. Results A total of 43 infants were <= 5 kg at the time of PEG insertion. The mean age was 5 +/- 3 (19 days-16 months) months and the mean weight was 4.3 +/- 0.6 (2.7-5.0) kg. The primary diagnoses were neurological disorders in 25, metabolic disorders in nine, cleft palates in four, muscular disorders in four, and a cardiac disorder in one. All procedures were completed successfully. A self-resolving pneumoperitoneum developed in one (2.3%). The tube was extruded in six (14%) patients postoperatively which required suture-approximation of the skin and subcuticular tissues. The tube was removed in four (9%) patients with achievement of oral feeds on the long-term. Eighteen (42%) died of primary diseases. The tubes were in situ for a median of 12.4 (17 days-73 months) months in these patients. A total of 20 (46.5%) patients are currently being followed up and their tubes are in situ for a median of 50.3 (4.7 month-9.8 years) months. Conclusions Percutaneous endoscopic gastrostomy placement is safe in small infants with associated morbidities. Complications related to the procedure are within acceptable limits. The accidental extrusion of the tube was a special consideration in this patient group. The overall mortality was high because of underlying primary diseases.
- 1 December 2020
- Published by Wiley in Pediatrics International
- Vol. 62 (12) , 1369-1373
Percutaneous endoscopic gastrostomy in small infants unable to swallow safely
Background Data about percutaneous endoscopic gastrostomy (PEG) insertions in small infants are limited, and most studies include older children. We aimed to evaluate the safety of PEG placement in infants weighing <= 5 kg together with their follow-up results. Methods A retrospective evaluation was made of records between January 2005 and December 2019. Results A total of 43 infants were <= 5 kg at the time of PEG insertion. The mean age was 5 +/- 3 (19 days-16 months) months and the mean weight was 4.3 +/- 0.6 (2.7-5.0) kg. The primary diagnoses were neurological disorders in 25, metabolic disorders in nine, cleft palates in four, muscular disorders in four, and a cardiac disorder in one. All procedures were completed successfully. A self-resolving pneumoperitoneum developed in one (2.3%). The tube was extruded in six (14%) patients postoperatively which required suture-approximation of the skin and subcuticular tissues. The tube was removed in four (9%) patients with achievement of oral feeds on the long-term. Eighteen (42%) died of primary diseases. The tubes were in situ for a median of 12.4 (17 days-73 months) months in these patients. A total of 20 (46.5%) patients are currently being followed up and their tubes are in situ for a median of 50.3 (4.7 month-9.8 years) months. Conclusions Percutaneous endoscopic gastrostomy placement is safe in small infants with associated morbidities. Complications related to the procedure are within acceptable limits. The accidental extrusion of the tube was a special consideration in this patient group. The overall mortality was high because of underlying primary diseases.
- 25 September 2020
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 34 (12) , 932-941
Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT
Objectives Gallium-68-labeled prostate-specific membrane antigen (Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) is a valuable diagnostic tool for the detection of bone metastases in patients with prostate cancer (PCa). However, bone scintigraphy (BS) with technetium-labeled diphosphonates is cheap and widely available for the same patient population. PSMA PET comes with a cost, and financial constraints in the present economic environment may require its more selective use. In this study, we aimed to compare the diagnostic performance of BS with Ga-PSMA PET/CT for the detection of bone metastases in patients with PCa and correlate the results with various clinical and biochemical variables. Materials and methods Ninety-five patients who underwent Ga-PSMA PET/CT and BS within 3 months for newly diagnosed or recurrent PCa were extracted from our database. Lesion, region and patient-based analyses were performed. Clinical and imaging follow-up was used as the reference test. Results were compared with tumor grade, serum prostate-specific antigen (PSA), and alkaline phosphatase (ALP) values. Results On the patient-based analysis, 75% (42/56) and 98.2% (55/56) of the patients with bone metastases were correctly diagnosed by BS and Ga-PSMA PET, respectively. In 26/95 patients with equivocal lesions on BS, Ga-PSMA PET correctly reclassified skeletal involvement in 11 and excluded metastases in 15 patients BS missed bone metastases in 3 patients. The true-positive rate of BS in patients with serum ALP ≥ 120U/L and PSA ≥ 50 ng/ml was 95.8% and 87.5 respectively. Conclusion Ga-PSMA is superior to BS for the evaluation of metastatic disease in patients with PCa. However, BS can also detect bone metastases in patients with PCa with a minimum sensitivity of 75%. Biochemical data are helpful to select patients with a high pretest probability who should undergo BS first as a part of the initial workup from an economic point of view. Due to its higher cost, Ga-PSMA PET should be performed in a selective group of patients when BS results are inconclusive or metastasis-directed therapy is planned.
- 25 September 2020
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 34 (12) , 932-941
Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT
Objectives Gallium-68-labeled prostate-specific membrane antigen (Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) is a valuable diagnostic tool for the detection of bone metastases in patients with prostate cancer (PCa). However, bone scintigraphy (BS) with technetium-labeled diphosphonates is cheap and widely available for the same patient population. PSMA PET comes with a cost, and financial constraints in the present economic environment may require its more selective use. In this study, we aimed to compare the diagnostic performance of BS with Ga-PSMA PET/CT for the detection of bone metastases in patients with PCa and correlate the results with various clinical and biochemical variables. Materials and methods Ninety-five patients who underwent Ga-PSMA PET/CT and BS within 3 months for newly diagnosed or recurrent PCa were extracted from our database. Lesion, region and patient-based analyses were performed. Clinical and imaging follow-up was used as the reference test. Results were compared with tumor grade, serum prostate-specific antigen (PSA), and alkaline phosphatase (ALP) values. Results On the patient-based analysis, 75% (42/56) and 98.2% (55/56) of the patients with bone metastases were correctly diagnosed by BS and Ga-PSMA PET, respectively. In 26/95 patients with equivocal lesions on BS, Ga-PSMA PET correctly reclassified skeletal involvement in 11 and excluded metastases in 15 patients BS missed bone metastases in 3 patients. The true-positive rate of BS in patients with serum ALP ≥ 120U/L and PSA ≥ 50 ng/ml was 95.8% and 87.5 respectively. Conclusion Ga-PSMA is superior to BS for the evaluation of metastatic disease in patients with PCa. However, BS can also detect bone metastases in patients with PCa with a minimum sensitivity of 75%. Biochemical data are helpful to select patients with a high pretest probability who should undergo BS first as a part of the initial workup from an economic point of view. Due to its higher cost, Ga-PSMA PET should be performed in a selective group of patients when BS results are inconclusive or metastasis-directed therapy is planned.
- 1 September 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (9) , 1898-1899
A retrospective evaluation of pediatric breast fibroadenomas with mid-term follow-up results
Click on the book chapter title to read more.
- 1 September 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (9) , 1898-1899
A retrospective evaluation of pediatric breast fibroadenomas with mid-term follow-up results
Click on the book chapter title to read more.
- 8 July 2019
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 44 (9) , e510-e516
Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients
Purpose: To assess the role of 68Gallium-labeled-prostate-specific membrane antigen PET/CT (68Ga-PSMA-PET/CT) in risk group definition and radiotherapy planning in the initially planned definitive radiotherapy (RT) for prostate cancer patients. Methods: The clinical data of 191 prostate cancer patients treated with definitive intensity-modulated RT were retrospectively analyzed. All patients were initially staged with thoracoabdominal CT and bone scintigraphy, and the second staging was performed using 68Ga-PSMA-PET/CT. Both stages were evaluated for the decision making of RT and any change in RT target volumes. Results: After staging with 68Ga-PSMA-PET/CT, 26 patients (13.6%) had risk group changes, 16 patients (8.4%) had an increase in risk group, and 10 patients (5.2%) had a decrease in risk group. Down-staging occurred in 22 patients (11.5%), and upstaging was observed in 30 patients (15.7%). A total of 26 patients (13.6%) had nodal stage changes. After the 68Ga-PSMA-PET/CT scans, the number of metastatic patient increased to 17 (8.9%), with 4 of them moving from oligo- to polymetastatic disease. An additional irradiation of pelvic lymphatics and metastatic site was performed in 13 patients (6.8%) and 6 patients (3.2%), respectively. The RT was aborted in 4 patients (2.1%) because of parenchymal or distant site metastasis observed in the 68Ga-PSMA-PET/CT. Conclusions: We found that 68Ga-PSMA-PET/CT causes considerable migration in stage, risk group, and RT field arrangements, especially in high-risk patients regardless of the GS and baseline prostate-specific antigen values alone. 68Ga-PSMA-PET/CT seems to have a great influence on RT decision making in prostate cancer patients.
- 8 July 2019
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 44 (9) , e510-e516
Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients
Purpose: To assess the role of 68Gallium-labeled-prostate-specific membrane antigen PET/CT (68Ga-PSMA-PET/CT) in risk group definition and radiotherapy planning in the initially planned definitive radiotherapy (RT) for prostate cancer patients. Methods: The clinical data of 191 prostate cancer patients treated with definitive intensity-modulated RT were retrospectively analyzed. All patients were initially staged with thoracoabdominal CT and bone scintigraphy, and the second staging was performed using 68Ga-PSMA-PET/CT. Both stages were evaluated for the decision making of RT and any change in RT target volumes. Results: After staging with 68Ga-PSMA-PET/CT, 26 patients (13.6%) had risk group changes, 16 patients (8.4%) had an increase in risk group, and 10 patients (5.2%) had a decrease in risk group. Down-staging occurred in 22 patients (11.5%), and upstaging was observed in 30 patients (15.7%). A total of 26 patients (13.6%) had nodal stage changes. After the 68Ga-PSMA-PET/CT scans, the number of metastatic patient increased to 17 (8.9%), with 4 of them moving from oligo- to polymetastatic disease. An additional irradiation of pelvic lymphatics and metastatic site was performed in 13 patients (6.8%) and 6 patients (3.2%), respectively. The RT was aborted in 4 patients (2.1%) because of parenchymal or distant site metastasis observed in the 68Ga-PSMA-PET/CT. Conclusions: We found that 68Ga-PSMA-PET/CT causes considerable migration in stage, risk group, and RT field arrangements, especially in high-risk patients regardless of the GS and baseline prostate-specific antigen values alone. 68Ga-PSMA-PET/CT seems to have a great influence on RT decision making in prostate cancer patients.
- 2 March 2019
- Published by Wiley in Pediatrics International
- Vol. 61 (5) , 504-507
Assessment of ovarian reserve using serum anti‐Müllerian hormone after ovarian torsion surgery
Background Determination of ovarian reserve by serum anti‐Müllerian hormone (AMH) levels in children who underwent either ovarian preserving surgery or oophorectomy because of ovarian torsion. Methods Patients operated on for unilateral ovarian torsion over ten years were contacted for the study with an ethical committee approval. Seventeen patients agreed to be included. Results There were ten patients who underwent ovarian detorsion and seven who underwent oopherectomy. The mean age at operation was 11.6±2.23 (8‐15) years and 13.2±2.17 (10‐16) years, respectively (p=0.46). The ovarian torsion was isolated in four patients in the first group and three in the second. The remaining had associated benign masses. At the time of this study, the mean age was 18±2.11 (14‐21) years with a mean postoperative follow‐up of 5.9±2.8 (2‐10.5) years. Echogenicity of all preserved ovaries was normal by pelvic Doppler ultrasonography with presence of antral follicles in 6. Three ovaries were smaller than expected for age, yet two of these had antral follicles. The mean AMH level was 5.54±2.25 ng/ml in the detorsion group and 2.70±2.11 ng/ml in the oopherectomy group (p=0.04). Conclusions Presence of follicles in preserved ovaries after detorsion was reported previously. AMH is expressed in granulosa cells of growing follicles and its serum level is valuable in assessing the quantitative aspects of the ovarian reserve. This study is unique by indicating preservation of the ovary in children with torsion is well justified in terms of future ovarian reserve.
- 2 March 2019
- Published by Wiley in Pediatrics International
- Vol. 61 (5) , 504-507
Assessment of ovarian reserve using serum anti‐Müllerian hormone after ovarian torsion surgery
Background Determination of ovarian reserve by serum anti‐Müllerian hormone (AMH) levels in children who underwent either ovarian preserving surgery or oophorectomy because of ovarian torsion. Methods Patients operated on for unilateral ovarian torsion over ten years were contacted for the study with an ethical committee approval. Seventeen patients agreed to be included. Results There were ten patients who underwent ovarian detorsion and seven who underwent oopherectomy. The mean age at operation was 11.6±2.23 (8‐15) years and 13.2±2.17 (10‐16) years, respectively (p=0.46). The ovarian torsion was isolated in four patients in the first group and three in the second. The remaining had associated benign masses. At the time of this study, the mean age was 18±2.11 (14‐21) years with a mean postoperative follow‐up of 5.9±2.8 (2‐10.5) years. Echogenicity of all preserved ovaries was normal by pelvic Doppler ultrasonography with presence of antral follicles in 6. Three ovaries were smaller than expected for age, yet two of these had antral follicles. The mean AMH level was 5.54±2.25 ng/ml in the detorsion group and 2.70±2.11 ng/ml in the oopherectomy group (p=0.04). Conclusions Presence of follicles in preserved ovaries after detorsion was reported previously. AMH is expressed in granulosa cells of growing follicles and its serum level is valuable in assessing the quantitative aspects of the ovarian reserve. This study is unique by indicating preservation of the ovary in children with torsion is well justified in terms of future ovarian reserve.